At present, metastatic and hormonal-refractory prostate cancer patients who have failed 1st line chemotherapy will be given mitoxantrone plus prednisone as the salvage therapy.  However, mitoxantrone plus prednisone is not very effective in controlling metastatic prostate cancer.  Now, a new drug developed by sanofi-aventis might offer hope to patients who have failed 1st line chemotherapy (docetaxel plus prednisone).

The new drug called cabazitaxel was investigated in the TROPIC trial that included 755 advanced prostate cancer patients who have failed 1st line docetaxel chemotherapy.  Half of the patients in the trial received combination of cabazitaxel and prednisone while the other half received mitoxantrone and prednisone.

Read more »

What is leukemia?

Leukemia is blood cancer that starts building up in connective tissue before spreading around the body. This connective tissue (bone marrow) forms stem cells that branch to form blood cells, e.g. red blood cells, white blood cells, platelets. Leukemia causes cells to form and divide uncontrollably. 
People with this abnormality develop an anomalous type of white blood cell called the leukemia cell. This cell keeps on accumulating and making it hard for normal cells to do their work in the body, i.e. they make it hard for other cells to function. 

Types of leukemia:

Read more »

Mesothelioma Attorney - Get What You Deserve

Are you sick? Were you exposed to asbestos? Unfortunately, Visit here http://mesotheliomatreatment-option.blogspot.com

asbestos was commonly used in the 1980's and millions of people were exposed to it. TodayVisit here http://mesotheliomatreatment-option.blogspot.com, we understand the risks that are involved when working with asbestos but we did not have this understanding when people were exposed to it every day. A common theory today is that companies were aware of the risks, dangers, and effects asbestos had on people working with it daily but did not warn their employees of the dangers involved. They did nothing to help protect the interests, health, and lives of their employees.

Read more »